BioSpace News Archive

It seems inevitable that as marijuana becomes more broadly legal in the U.S., that the biopharma industry and larger corporations will take an interest.

The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Human Longevity Clinical Labs LLC, San Diego, California, based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

NBA Champion and mental health advocate Metta World Peace will be honored at the second annual Mental Health Heroes Awards Luncheon on May 9, 2018, at 11:30 a.m. at The Olympic Collection in West Los Angeles.

Streamline Health Solutions, Inc. announced that it will release its fourth quarter and Fiscal Year 2017 financial performance for the period that ended January 31, 2018, on Wednesday, April 25, 2018 after the market closes.

eurocrine Biosciences, Inc. announced that new data for once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive dyskinesia (TD), will be presented at the American Academy of Neurology (AAN) Annual Meeting in Los Angeles, Calif., April 21-27, 2018.

Anika Therapeutics, Inc. announced that the Company plans to issue its first-quarter 2018 financial results after the close of the market on Wednesday, May 2, 2018

Pulse Biosciences, Inc. announced that the Compensation Committee of the company’s Board of Directors granted non-qualified stock options covering an aggregate of 300,000 shares of Pulse Biosciences common stock to one new employee under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on April 16, 2018.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2018 on Tuesday, May 8, 2018, following the close of the market.

Sinovac Biotech Ltd. today issued the following statement to set the record straight following a series of false statements and damaging actions by Shandong Sinobioway Biomedicine Co., Ltd. intended to mislead and publicly harm the interest of Sinovac and our shareholders.

Zimmer Biomet Holdings, Inc. announced an agreement with Oregon Surgical Institute.